Summary
The sample “Cytomed 25” from DEUS Medical underwent qualitative and quantitative analysis. Testing confirmed the presence of T3 (liothyronine) with measured concentrations of 23.34 mcg in the first pill and 25.49 mcg in the second pill.
Testing was ordered and conducted on 23-24 November 2020.
Detailed Report
Product Overview
- Manufacturer: DEUS Medical
- Product Name: Cytomed 25
- Active Ingredient: T3 (Liothyronine)
- Batch Number: DM91666
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #09191
- Testing Ordered: 23 November 2020
- Sample Received: 23 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP (Reseller)
- Analysis Paid For By: DEUSPOWER.SHOP (Reseller)
Testing Results
- Identified Compound: T3 (Liothyronine)
- First Pill Concentration: 23.34 mcg
- Second Pill Concentration: 25.49 mcg
Verification Details
- Verification URL: https://janoshik.com/tests/09191_HE5UM6596XRP
Evaluation of Reseller-Submitted Testing
The test confirms the presence of T3 in the Cytomed 25 pills with slight variation in dosages (23.34 mcg and 25.49 mcg). These concentrations are within an acceptable range for pharmaceutical manufacturing variances.
Conclusion
The results confirm the presence and expected dosage of T3 in the sample, indicating authenticity and compliance with expected formulation standards.
Disclaimer
This report is for educational purposes and highlights findings based on reseller-submitted testing. Independent third-party testing is advised for comprehensive validation.
